Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy.
about
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome.Treatment Options in Hepatitis C.Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States.Last gasps of the hepatitis C virus dragon: Direct acting antiviral failures and hepatitis C virus-positive donors.Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments.Sofosbuvir and velpatasvir: a stellar option for patients with decompensated hepatitis C virus (HCV) cirrhosis.Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.The dynamic landscape of liver transplant in the era of effective hepatitis C virus therapy.Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study.HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
P2860
Q31160142-21C234D2-ADA6-46E7-90C3-CC9B1D9E3F79Q38663336-DE99D32B-AC73-4368-9ADE-18FA869BD2DFQ39112237-D3430F1D-B674-4F91-9CEC-0E47C9CC02FBQ39139767-D56B0A10-8311-46A8-944D-878AD0BE79C3Q39203624-BF538BEF-53CE-4E06-B4D6-ACB19AFD1762Q40236932-7CC54F88-EDF4-4132-AE1C-343E3D2087D7Q40309524-ED8AB736-0D6D-4310-81D3-A54B4F1B8BF0Q40516026-F872349B-673D-45E8-A77F-80C8B945EC4FQ40582320-BD31790F-8D5E-4CC3-B417-55D8D660BD40Q41017630-28436DB0-2AA5-4478-BE36-707A8AEDEB73Q41930571-2A4C21F6-9E0D-41CD-B332-693BF5DBA3CBQ42370325-700C3D25-F13A-46BB-B7DB-1FE952AD2EBFQ45323547-540708BA-2237-42C4-A35F-8A76DFA5D8E9Q45330991-8CE95895-C38C-4BEB-B49A-DBF1386140A6Q47546983-CA6298C0-43EE-4626-9E7F-012348C35689Q47555750-04F005EA-E85B-46F7-95DE-7D45F1BA23F0Q50067192-93118FDD-9097-437F-8657-0C1A6630D12BQ55027157-B2C75D1A-7DE6-4864-A9F5-E75949D495E6Q55223377-F87A077A-4EC1-4128-8EF7-7DF67890F98CQ58788714-31DFC290-A5E5-429F-AEC1-5CBEE47BC4D6
P2860
Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treat chronic hepatitis C viru ...... ve and well-tolerated therapy.
@en
type
label
Treat chronic hepatitis C viru ...... ve and well-tolerated therapy.
@en
prefLabel
Treat chronic hepatitis C viru ...... ve and well-tolerated therapy.
@en
P2860
P356
P1476
Treat chronic hepatitis C viru ...... ve and well-tolerated therapy.
@en
P2093
C Bunchorntavakul
P2860
P304
P356
10.1111/JVH.12534
P577
2016-03-28T00:00:00Z